EXPLORING THE UNKNOWN: USE OF SENSITIVITY ANALYSIS TO CHARACTERIZE RESIDUAL UNCERTAINTY IN REAL-WORLD EXTERNAL CONTROL ARM EVIDENCE SUBMITTED TO NICE

被引：0
|
作者：
Leahy, T. [1 ]
Keenan, C. [1 ]
Robertshaw, E. [1 ]
Mcstravick, M. [2 ]
Sammon, C. [1 ]
Turner, A. [1 ]
机构：
[1] Putnam Associates, London, England
[2] Putnam Associates, Newcastle Upon Tyne, England
来源：
VALUE IN HEALTH | 2024年 / 27卷 / 12期
关键词：
D O I：
暂无
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
P2
引用
收藏
页数：2
相关论文
共 50 条
  • [21] Exploring uncertainty and use of real-world data in the National Institute for Health and Care Excellence single technology appraisals of targeted cancer therapy
    Jiyeon Kang
    John Cairns
    BMC Cancer, 22
  • [22] FEASIBILITY OF USING FINNISH REAL-WORLD DATA TO BUILD AN EXTERNAL CONTROL ARM FOR THE FACTOR XIA INHIBITOR ASUNDEXIAN PACIFIC-AF TRIAL
    Potts, J.
    Laapas, K.
    Khorlo, I
    Niemela, P.
    Strom, S.
    Partanen, L.
    Kurki, S.
    Viethen, T.
    Abdelgawwad, K.
    Leinonen, J.
    VALUE IN HEALTH, 2023, 26 (12) : S400 - S400
  • [23] Colitis following the use of immune checkpoint inhibitors: A real-world analysis of spontaneous reports submitted to the FDA adverse event reporting system
    Hu, Yingying
    Gong, Jian
    Zhang, Lifu
    Li, Xiaolin
    Li, Xina
    Zhao, Bin
    Hai, Xin
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2020, 84
  • [24] EXPLORING EFFICIENCY OF LIVING SYSTEMATIC LITERATURE REVIEW (SLR) TOOL FOR SUBMISSIONS OF CLINICAL EVIDENCE TO NATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE (NICE) BY COMBINING INTERVENTIONAL AND REAL-WORLD EVIDENCE (RWE)
    Liu, R.
    Agranat, J.
    Rizzo, M.
    Forsythe, A.
    VALUE IN HEALTH, 2023, 26 (12) : S349 - S349
  • [25] Real-world emissions from modern heavy-duty vehicles: Sensitivity analysis of in-use emissions analysis methods
    Demirgok, Berk
    Thiruvengadam, Arvind
    Pradhan, Saroj
    Besch, Marc
    Thiruvengadam, Pragalath
    Posada, Francisco
    Quiros, David C.
    Hu, Shaohua
    ATMOSPHERIC ENVIRONMENT, 2021, 252
  • [26] A FRAMEWORK FOR CONDUCTING PROBABILISTIC SENSITIVITY ANALYSIS (PSA) WHEN MODELING WITH REAL-WORLD EVIDENCE (RWE) - HOW GOOD IS THE GUIDANCE?
    Ramjee, L.
    Tremblay, G.
    VALUE IN HEALTH, 2020, 23 : S291 - S291
  • [27] Quantitative bias analysis for external control arms using real-world data in clinical trials: a primer for clinical researchers
    Thorlund, Kristian
    Duffield, Stephen
    Popat, Sanjay
    Ramagopalan, Sreeram
    Gupta, Alind
    Hsu, Grace
    Arora, Paul
    Subbiah, Vivek
    JOURNAL OF COMPARATIVE EFFECTIVENESS RESEARCH, 2024, 13 (03)
  • [28] REWENEC: REal-World Evidence in NEC provides a reliable external control arm to avoid randomization for second-line clinical trials - A post hoc proof of concept analysis with the randomized phase II BEVANEC study
    Hadoux, J.
    Ganame, S.
    Lievre, A.
    Durand, A.
    Tougeron, D.
    Perrier, M.
    Scoazec, J-Y.
    Baudin, E.
    Gerard, L.
    Lepage, C.
    Boussari, O.
    Walter, T.
    ANNALS OF ONCOLOGY, 2023, 34 : S501 - S502
  • [29] Investigating the Variability among Indicators for Quantifying Antimicrobial Use in the Intensive Care Units: Analysis of Real-world Evidence
    Deshwal, Prity R.
    Tiwari, Pramil
    INDIAN JOURNAL OF CRITICAL CARE MEDICINE, 2024, 28 (07) : 662 - 676
  • [30] Luminous: Results from the 2014 Interim Analysis to Provide Further Real-World Evidence for Clinical Ranibizumab Use
    Brand, Christopher
    OPHTHALMOLOGICA, 2014, 232 : 4 - 5
12345